These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29778321)

  • 41. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy.
    Millunchick CH; Zhen H; Redler G; Liao Y; Turian JV
    J Appl Clin Med Phys; 2018 Mar; 19(2):48-53. PubMed ID: 29105949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneity.
    Tol JP; Dahele M; Doornaert P; Slotman BJ; Verbakel WF
    Med Phys; 2014 Feb; 41(2):021722. PubMed ID: 24506613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Establishment and application of new techniques for submandibular gland preservation].
    Yu GY; Su JZ; Liu DG; Wu LL; Cong X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):842-845. PubMed ID: 36241226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
    Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
    Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sparing the contralateral submandibular gland in oropharyngeal cancer patients: a planning study.
    Houweling AC; Dijkema T; Roesink JM; Terhaard CH; Raaijmakers CP
    Radiother Oncol; 2008 Oct; 89(1):64-70. PubMed ID: 18501984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation.
    Nangia S; Chufal KS; Arivazhagan V; Srinivas P; Tyagi A; Ghosh D
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):485-92. PubMed ID: 16909973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modification of the submandibular gland transfer procedure.
    Marzouki HZ; Elkhalidy Y; Jha N; Scrimger R; Debenham BJ; Harris JR; O'Connell DA; Seikaly H
    Laryngoscope; 2016 Nov; 126(11):2492-2496. PubMed ID: 27171786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Chang CF; Ei-Sayed IH; George JR; Heaton CM; Ryan WR; Susko MS; Yom SS; Ha PK
    Head Neck; 2020 Sep; 42(9):2340-2347. PubMed ID: 32400948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five-year outcomes of sparing level IB in node-positive, human papillomavirus-associated oropharyngeal carcinoma: A safety and efficacy analysis.
    Ross RB; Juloori A; Varra V; Ward MC; Campbell S; Woody NM; Murray E; Xia P; Greskovich JF; Koyfman SA; Joshi NP
    Oral Oncol; 2019 Feb; 89():66-71. PubMed ID: 30732961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Fan WJ; Teng F; Liu G; Zhao DW; Li JF; Luo YR; Zhang XX; Ma L; Guan J
    Radiother Oncol; 2021 Apr; 157():247-254. PubMed ID: 33587972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.
    Tol JP; Dahele M; Delaney AR; Doornaert P; Slotman BJ; Verbakel WF
    Med Phys; 2016 Apr; 43(4):1818. PubMed ID: 27036579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.